CETOACIDOSIS DIABETICA EN PEDIATRIA PDF
no necesariamente significa diabetes. Sament y Schwartz () diferenciaron la hiperglucemia sin cetosis y la cetoacidosis diabética Entre la etiología de la. que cuente con experiencia en diabetes pediátrica, si esto es posible. El tratamiento de La Cetoacidosis diabética (CAD) se produce cuando hay deficiencia. Cetoacidosis diabética pediátrica en paciente con síndrome de Down. Diabética; Síndrome de Down; Diabetes Mellitus Tipo 1; Pediatría. . Vistas PDF.
|Language:||English, Spanish, Portuguese|
|ePub File Size:||23.70 MB|
|PDF File Size:||16.23 MB|
|Distribution:||Free* [*Registration Required]|
MA, USA; bBarts Health NHS Trust, Royal London Hospital,. London, UK; cInstitute of Endocrinology and Diabetes, The. Children's Hospital at Westmead; . Download scientific diagram | Tratamiento de la cetoacidosis diabética en el niño . Protocolo auge diabetes tipo 1. from publication: Consenso en el diagnóstico. y estos planes deben usarse con precaución para aquellos que toman inhibidores de SGLT2 debido al riesgo potencial de cetoacidosis.
Clin- and effective communication with a health ically, cerebral edema is characterized by care provider during an intercurrent illness. Phosphate deterioration in the level of conscious- The observation that stopping insulin for Despite whole-body phosphate deficits in ness, lethargy, decreased arousal, and economic reasons is a common precipi- DKA that average 1. Neurological deterioration tant of DKA in urban African Americans body wt—1, serum phosphate is often may be rapid, with seizures, inconti- and Hispanics 2,76,77 underscores the normal or increased at presentation.
These symptoms to address this problem, which is costly insulin therapy. Prospective randomized progress as brain stem herniation occurs. Sick-day man- studies 63,64 have failed to show any The progression may be so rapid that pap- agement should be reviewed periodically beneficial effect of phosphate illedema is not found. Once the clinical with all patients.
Therefore, the routine use of covering without permanent morbidity. However, to avoid car- osmotically driven movement of water ible liquid diet containing carbohydrates diac and skeletal muscle weakness and into the central nervous system when and salt. Most importantly, the patient respiratory depression due to hypophos- plasma osmolality declines too rapidly should be advised to never discontinue phatemia, careful phosphate replacement with the treatment of DKA or HHS 72— insulin and to seek professional advice may sometimes be indicated in patients However, a recent study 75 using early in the course of the illness.
In Handbook of record blood glucose, urine, or blood ke- Diabetes Mellitus. Brownlee M, Ed.
Rivera Brenes, Ramon
Chupin M. Hillman K: Fluid resuscitation in diabetic sional. Adequate supervision and help American Diabetes Association, and the Abe emergencies: a reappraisal. Intensive Care from staff or family may prevent many of Goodman Fund. Med — 8, the admissions for HHS due to dehydra- Delaney MF, Zisman A, Kettyle WM: dia- tion among elderly individuals who are betic ketoacidosis and hyperglycemic unable to recognize or treat this evolving References hyperosmolar nonketotic syndrome.
Diabetes Care —, the renaissance of carnitine palmitoyl- worsen diabetes control; and the use of 2. Arch Intern Med Diabetes with hyperglycemic crises. Diabetes with diabetes, with a trend toward an in- Rev —, —, creased hospitalization rate in the past 2 4.
Newcomer JW: Second generation atyp- decades. The incidence of HHS accounts hyperosmolar hyperglycemic syndrome. CNS sions. Significant resources are spent on 5. DKA episodes Acute metabolic complications in diabe- In Diabetes in America.
Care —, Lorber D: Nonketotic hypertonicity in di- betic ketoacidosis during long-term treat- sodes. Based on an annual average of abetes mellitus.
Med Clin North Am ment with continuous subcutaneous , hospitalizations for DKA in the 39 —52, insulin infusion. Diabetes Care —5, U. Kreisberg RA: Diabetic ketoacidosis: an patient 79 , the annual hospital cost for update. Crit Care Clin — , Diabetes Care — could be avoided by devoting adequate osmolarity and acidosis in diabetes , resources to apply the measures de- mobility. J Gen Int Met —, Because repeated admis- 9.
J Am Geriatr Soc In International Text- dissection of a heterogeneous syndrome us- better access to care and educational pro- book of Diabetes Mellitus.
De- ing an immunogenetic and beta-cell func- grams tailored to individual needs, in- Fronzo RA, Ferrannini E, Keen H and tional classification, prospective analysis, cluding ethnic and personal health care Zimmet P, Eds.
J Clin Endocrinol beliefs. In addition, resources should be Chichester, U. Wachtel TJ: The diabetic hyperosmolar in patients of sub-Saharan African origin: diabetes can be diagnosed earlier. This has state. Clin Geriatr Med — , clinical pathophysiology and natural his- been shown to decrease the incidence of Diabetes — , molar nonketotic coma. Diabetes — Am J Clin Pathol — abetic patients. Diabetes Kelly AM: The case for venuous rather —, Rumbak MJ: Diabetic ketoacidosis and than arterial blood gages in diabetic keto- Phila- Am J Med pathogenesis for obese and lean African- — , Americans with diabetic ketoacidosis.
Dia- N Engl J Med with initial hypokalemia: therapeutic im- Kitabchi AE: Editorial: Ketosis-prone dia- 97—98, plications.
JAMA — , betes: a new subgroup of patients with Arch Iranian Med —, bonate therapy improve the management Matz R: Hypothermia in diabetic acidosis.
Int J Clin Pract — diabetic metabolic decompensation: clin- , JAMA —, Ann Intern Med — , Arch Intern Med — Kitabchi AE, Ayyagari V, Guerra SM: The study of phosphate therapy in the treat- efficacy of low-dose versus conventional ment of diabetic ketoacidosis. J Clin Endo- Ann Intern Med Barsotti MM: Potassium phosphate and cyte count and differential as early predic- — , potassium chloride in the treatment of di- tors of infection.
Am J Emeg Med —5, Kitabchi AE: Low dose insulin therapy in abetic ketoacidosis.
Diabetes Care , diabetic ketoacidosis: fact or fiction. Am J Med — Rumbak MJ, Hughes TA, Kitabchi AE: tinuous intravenous regular insulin for , Pseudonormoglycaemia in diabetic keto- the treatment of patients with diabetic ke- Keller V, Berger W: Prevention of hy- acidosis with elevated triglycerides.
Am J toacidosis.
Am J Med —, pophosphalemia by phosphate infusion Emerg Med — 63, Diabetes — Eknoyan G: Determinants of plasma po- diabetic ketoacidosis with subcutaneous 95, tassium levels in diabetic ketoacidosis. Infect Dis Clin N Am ; Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components.
Eur J Cell Biol ;70 1 Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev ;18 3 Damage to Aspergillus fumigatus and Rhizopus oryzae hyphae by oxydative and nonoxidative microbicidal products of human neutrophils in vitro.
Infect Immunol ; Zygomycosis in a tertiary- care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis ; 8 Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.
The effect of pH on the kinetics of iron release from human transferrin.
Hyperglycemic Crises in Adult Patients
Biochim Biophys Acta ; Iron gathering of opportunistic pathogenic fungi. A mini review.
Acta Microbiol Immunol Hung ; Mucormycosis during deferoxamine therapy is a siderophore mediated infection: in vitro and in vivo animal studies. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients. Nephrol Dial Transplant ;7 9 Rhynocerebral mucormycosis.
Nueva Guía sobre Diabetes (ADA)
Otolaryngol ; 10 Survival factors in rhinoorbital- cerebral mucormycosis. Surv Ophthalmol ;39 1 MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathological correlation.
Magn Reson Imaging ; Pulmonary mucormycosis: radiologic findings in 32 cases. Zygomycetes in human disease. Clin Microbiol Rev ;13 2 Clinical Infectious Diseases ; Peritonitis due to Rhizopus in a patient undergoing continuous ambulatory peritoneal dialysis.
Rev Infect Dis ;13 1 Mucormycosis of the trachea: an unusual cause of acute upper airway obstruction. Chest ;81 5 Mucor mediastinitis. Chest ;75 4 Primary renal mucormycosis. Urology ;52 5 : Splenic mucormycosis. Rhizopus osteomyelitis. A case report and review. Am J Med ;66 1 Superior vena cava syndrome due to mucormycosis in a patient with lymphoma.
Mt Sinai J Med ;54 6 Zygomycosis: conventional laboratory diagnosis. Dannaoui E. Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Combination polyene- caspofungin treatment of Rhino-Orbital-Cerebral Mucormycosis.
Clin Infect Dis ; The experience of living with type 1 diabetes and attending clinic from the perception of children, adolescents and carers: analysis of qualitative data from the DEPICTED study. Trends in the incidence of childhood-onset diabetes in Europe Diabetes with diabetes, with a trend toward an in- Rev —, —, creased hospitalization rate in the past 2 4.
Las manifestaciones reflejan el compromiso secuencial de la nariz, senos paranasales ojo y cerebro. En cuanto a la neutropenia, se han utilizado factores de crecimiento o factor estimulante de colonias de granulocitos G-CSF y transfusiones de granulocitos mobilizados GTX.
Kelly AM: The case for venuous rather —, Rumbak MJ: Diabetic ketoacidosis and than arterial blood gages in diabetic keto- Clin Microbiol Infect ; 15 suppl. Indian J Pediatr.